These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2412419)

  • 21. Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome.
    Baron GC; Klimas NG; Fischl MA; Fletcher MA
    Diagn Immunol; 1985; 3(4):197-204. PubMed ID: 3866646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
    Ljunggren K; Karlson A; Fenyö EM; Jondal M
    Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon modulation of natural killer cell activity.
    Perussia B; Santoli D; Trinchieri G
    Ann N Y Acad Sci; 1980; 350():55-62. PubMed ID: 6165304
    [No Abstract]   [Full Text] [Related]  

  • 24. Natural killer cell activity as a prognostic parameter in the progression to AIDS.
    Voth R; Rossol S; Gräff E; Laubenstein HP; Schröder HC; Müller WE; Meyer zum Büschenfelde KH; Hess G
    J Infect Dis; 1988 Apr; 157(4):851-2. PubMed ID: 3346577
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphadenopathy: end-point prodrome? Update of a 36-month prospective study.
    Abrams DI; Mess T; Volberding PA
    Adv Exp Med Biol; 1985; 187():73-84. PubMed ID: 2994422
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human natural killer cells.
    Trinchieri G; Perussia B; Santoli D; Cerottini JC
    Transplant Proc; 1979 Mar; 11(1):807-10. PubMed ID: 452106
    [No Abstract]   [Full Text] [Related]  

  • 28. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
    Smith PD; Ohura K; Masur H; Lane HC; Fauci AS; Wahl SM
    J Clin Invest; 1984 Dec; 74(6):2121-8. PubMed ID: 6511917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's new in natural killer cells?
    Boekstegers A; Grundmann E
    Pathol Res Pract; 1985 Nov; 180(5):536-52. PubMed ID: 2417213
    [No Abstract]   [Full Text] [Related]  

  • 30. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RR; Ortaldo JR; Bonnard GD
    Nature; 1979 Jan; 277(5693):221-3. PubMed ID: 95205
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages.
    Herberman RB; Ortaldo JR; Djeu JY; Holden HT; Jett J; Lang NP; Rubinstein M; Pestka S
    Ann N Y Acad Sci; 1980; 350():63-71. PubMed ID: 6165306
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular interactions in the augmentation of human NK activity by interferon.
    Saksela E; Timonen T; Cantell K
    Ann N Y Acad Sci; 1980; 350():102-11. PubMed ID: 6165264
    [No Abstract]   [Full Text] [Related]  

  • 33. Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome.
    Euler HH; Kern P; Löffler H; Dietrich M
    Clin Exp Immunol; 1985 Feb; 59(2):267-75. PubMed ID: 3156700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance of primitive cells by natural killer cells.
    Kiessling R; Wigzell H
    Curr Top Microbiol Immunol; 1981; 92():107-23. PubMed ID: 6171383
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphocytotoxic antibodies to non-HLA antigens in the sera of patients with acquired immunodeficiency syndrome (AIDS).
    Pollack MS; Callaway C; LeBlanc D; Robinson HM; Mastrota F; Dupont B; Koziner B
    Prog Clin Biol Res; 1983; 133():209-13. PubMed ID: 6604922
    [No Abstract]   [Full Text] [Related]  

  • 36. Natural killing activity and interferon production in multiple sclerosis.
    Zander H; Abb J; Kaudewitz P; Riethmüller G
    Lancet; 1982 Jan; 1(8266):280. PubMed ID: 6173558
    [No Abstract]   [Full Text] [Related]  

  • 37. AIDS, Kaposi sarcoma, and the lymphatic system: update and reflections.
    Witte MH; Witte CL; Way DL; Fiala M
    Lymphology; 1990 Jun; 23(2):73-80. PubMed ID: 2214866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
    Quinnan GV; Rook AH
    Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
    [No Abstract]   [Full Text] [Related]  

  • 39. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
    Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
    Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.